Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Pozycja w akcjach #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Cena akcji
$0.16328419
Kapitalizacja rynkowa
$204.14K
Zmiana (1 dzień)
4.35%
Zmiana (1 rok)
102.45%
Kraj
GB
Handel Fusion Antibodies plc (FAB)

Kategoria

EPS dla Fusion Antibodies plc (FAB)
EPS na dzień September 2025 TTM: $-0.02
Według najnowszych raportów finansowych i ceny akcji firmy Fusion Antibodies plc, obecny EPS (TTM) wynosi $-0.02. Na koniec roku 2024 firma miała EPS w wysokości $-0.05, spadek w porównaniu do do EPS z roku 2023, który wynosił $-0.12.
Historia EPS dla Fusion Antibodies plc od 2013 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL